TABLE 2

Changes of σ-Receptor Populations in C6 Tumors After Doxorubicin Treatment

PopulationBmax (fmol/mg of protein)Kd (nM)
σ1-Receptor
 Saline-treated172 ± 1321.3 ± 0.5
 Doxorubicin-treated125 ± 1219.6 ± 1.8
P<0.05NS
σ2-Receptor
 Saline-treated152 ± 1117.0 ± 1.6
 Doxorubicin-treated112 ± 1616.8 ± 1.5
P0.07NS
  • NS = not statistically significant.

  • Data are mean ± SEM.